Douglas A Hettrick

This inventor holds 93 USPTO granted patents and 34 published patent applications and 28 EPO patents, primarily in Renal Neuromodulation (CPC class A61B2018-00434). Top assignees: Medtronic, Inc., Medtronic Ardian Luxembourg S.a.r.l., Medtronic Ireland Manufacturing Unlimited Company. Active years: 2005-2026.

USPTO Granted Patents = 93 (Patent Applications = 34)

% Patents Active = 91.4

EPO Patents = 28 (Patent Applications = 32)

Average Co-Inventor Count = 2.9

ph-index = 17

Forward Citations = 1,129(Granted Patents)

Forward Citations (Not Self Cited) = 996(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Blaine, MN (US) (2005 - 2014)
Maple Grove, MN (US) (2014)
Santa Rosa, CA (US) (2020 - 2023)
Andover, MN (US) (2008 - 2024)

Company Filing History:

Medtronic Ardian Luxembourg S.a.r.l.

patents

13 out of 56

Medtronic Ireland Manufacturing Unlimited Company

patents

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Neuromodulation

Renal Therapy

Heart Failure

Depression Treatment

Anxiety Disorders

Cognitive Impairment

Sensing Techniques

Hemodynamic Responses

Denervation Therapy

Post-Traumatic Stress Disorder

Eating Disorders

Sympathetic Tone Assessment

93 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12697037 - Prenatal monitoring system (2026-08-04),

2. 12667425 - Methods and systems for optimizing perivascular neuromodulation therapy using computational fluid dynamics (2026-06-30),

3. 12594118 - Systems, devices, and associated methods for neuromodulation with enhanced nerve targeting (2026-04-07),

4. 12350028 - Systems and methods for assessing efficacy of renal neuromodulation therapy (2025-07-08),

5. 12226220 - Systems and methods for assessing sympathetic nervous system tone for renal neuromodulation therapy (2025-02-18),

6. 12150699 - Methods for treating depression in patients via renal neuromodulation (2024-11-26),

7. 12082917 - Systems, devices, and methods for assessing efficacy of renal neuromodulation therapy (2024-09-10),

8. 12076089 - Denervation therapy (2024-09-03),

9. 12064226 - Systems and methods for evaluating neuromodulation therapy via hemodynamic responses (2024-08-20),

10. 11890047 - Methods for treating anxiety disorders in patients via renal neuromodulation (2024-02-06),

11. 11865343 - Methods for treating post-traumatic stress disorder in patients via renal neuromodulation (2024-01-09),

12. 11864904 - Systems, devices, and methods for evaluating neuromodulation therapy via detection of magnetic fields (2024-01-09),

13. 11844568 - Systems, devices, and associated methods for neuromodulation with enhanced nerve targeting (2023-12-19),

14. 11844558 - Methods for treating eating disorders in patients via renal neuromodulation (2023-12-19),

15. 11723537 - Heart failure monitoring (2023-08-15),

Title: Inventor Douglas A Hettrick - Pioneering Innovations in Blaine, MN

Introduction: Douglas A Hettrick is a distinguished inventor based in Blaine, MN, known for his groundbreaking contributions to various fields.

Latest Patents: Douglas A Hettrick holds several patents in the areas of technology and engineering, showcasing his continuous commitment to innovation.

Career Highlights: Throughout his career, Douglas A Hettrick has demonstrated a remarkable ability to transform ideas into tangible inventions that have the potential to shape the future.

Collaborations: Douglas A Hettrick has collaborated with leading companies and research institutions, leveraging his expertise to drive forward cutting-edge projects.

Conclusion: Inventor Douglas A Hettrick's passion for innovation and his relentless pursuit of excellence make him a prominent figure in the world of inventions.